Another Possible Treatment Option for Intermediate-Stage Liver Cancer Adding lenvatinib, pembrolizumab to TACE significantly improved PFS, numerically improved OS Sep 16, 2024
Chemo-Free Triplet Yields 68% Response Rate in Richter Transformation Regimen tops best historical response rate with chemoimmunotherapy in this setting Sep 16, 2024
Radionuclide-Containing Combo Slows Metastatic Prostate Cancer, Improves Survival Hazards for radiographic PFS, OS reduced by 31% with enzalutamide plus Ra-223 Sep 15, 2024
Retifanlimab-Chemo Combo Boosts PFS in Advanced Squamous Cell Anal Cancer POD1UM-303/InterAACT 2 data also trend in the direction of better overall survival Sep 15, 2024
No Survival Gain With Preoperative CRT Plus Perioperative Chemo for Gastric Cancer But combination may be appropriate for shrinking tumors before surgery Sep 14, 2024
Another Win for Antibody-Drug Conjugate in HER2+ Breast Cancer With Brain Mets Second-line T-DXd best option in patients with and without intracranial activity, experts says Sep 14, 2024
Screening After False Positive Mammograms; RSV Vaccination and Hospitalization Also in TTHealthWatch: time from approval to reimbursement for new drugs Sep 14, 2024 podcast
No PFS Benefit With Immune Checkpoint Inhibitor Rechallenge in Renal Cell Carcinoma Data support that ICI rechallenge should be discouraged in patients with advanced RCC Sep 13, 2024
Cancer Diagnoses Still Lagging; Cancer and Family Health; New Type of Lung Cancer News, features, and commentary about cancer-related issues Sep 12, 2024
How a California Oncologist Making $850k Spends Money See the breakdown of this physician's weekly budget, from eating out to sailing lessons Sep 12, 2024
Second Malignancy Risk With CAR T-Cell Therapy on Par With Other Treatments Incidence almost identical to that with standard cancer treatment in randomized trials Sep 11, 2024
Antibody Drug-Conjugate Shows Promising Activity in Extensive-Stage SCLC Objective response rate was 55% with 12-mg/kg ifinatamab deruxtecan Sep 11, 2024
Limits to Anti-Nausea Pill Coverage Wear on Cancer Patients and Doctors "This is sort of the dirty underbelly of the current healthcare environment," an oncologist said Sep 11, 2024
Added Plinabulin Boosts OS as Later-Line Treatment for EGFR Wild-Type NSCLC However, plinabulin plus docetaxel still "not ready for prime time," expert says Sep 10, 2024
MET Inhibitor Increases Osimertinib Activity in EGFR+ Advanced NSCLC Absolute improvement of almost 30%, doubling of duration of response with savolitinib Sep 10, 2024
Did U.S. Government Play a Role in Remote Tribe's Widespread Illness and Cancer? Toxins are embedded in the soil, but no one can say what has caused such widespread illness Sep 10, 2024
Perioperative Nivolumab Boosts EFS Versus Neoadjuvant-Only Nivolumab in NSCLC Two-trial analysis shows about a 40% decreased risk of disease recurrence or death Sep 09, 2024
Study Supports Lactated Ringer Solution for Fluid Resuscitation in SCD For patients with vaso-occlusive episodes, lactated Ringer was better than normal saline Sep 09, 2024
Ivonescimab Tops Pembrolizumab in PD-L1-Positive, Advanced NSCLC Novel agent nearly halved risk of progression as first-line therapy in phase III trial Sep 09, 2024
Kate Middleton Reaches Cancer Treatment Milestone Princess of Wales says she will return to some public duties Sep 09, 2024
Novel Drugs Boost Immunotherapy Activity in Resectable Lung Cancer Add-on ADC, monoclonal antibody consistently increase pCR versus PD-1 inhibitor plus chemotherapy Sep 09, 2024
Comparing Fecal Immunochemical Tests; CVD Blood Test for Women Also in TTHealthWatch: beta-blockers after MI Sep 07, 2024 podcast
Study Backs Skipping 5-FU Bolus in Chemo Regimens for Gastrointestinal Cancers No difference in overall survival with versus without bolus, less toxicity without Sep 05, 2024
Women With HCC Less Likely to Receive Liver Transplant, More Likely to Die Than Men This difference is mostly explained by their smaller stature, researchers say Sep 05, 2024
No Cellphone, Brain Cancer Link; Testosterone Paradox; Breast Density and Cancer News, features, and commentary about cancer-related issues Sep 05, 2024
Doxorubicin-Trabectedin Strategy Boosts Survival in Challenging Sarcoma Combination for leiomyosarcoma improved OS by 9 months versus doxorubicin alone Sep 04, 2024
Off-the-Shelf Drug Matches CAR-T Effects in Refractory Lupus Patient achieves remission with biologic agent currently used for myeloma Sep 04, 2024
The Higher the Disability Burden From Disease, the Higher the Suicide Risk Having a medical condition was tied to increased risk of suicide in a dose-response-like manner Sep 04, 2024
Infections the Main Cause of Nonrelapse Mortality After CAR-T for Blood Cancers Systematic review and meta-analysis finds CAR T-cell-specific toxicities only account for 11.5% Sep 04, 2024
Cell Phones and Brain Cancer; Bogus Doctor Faces New Charges; Cannabis Rescheduling Health news and commentary gathered by Ƶ staff Sep 04, 2024
BTK Inhibitor Active in Half of Patients With Richter Transformation Responses to pirtobrutinib observed in patients with previously treated disease Sep 03, 2024
False-Positive Mammograms May Discourage Subsequent Screenings Recommendations for short-interval follow-up or biopsy likely a factor Sep 02, 2024
Oncologist Sued for Double-Billing; Pharmacy Deserts; 'She Loved Scotch and Pizza' News, features, and commentary about cancer-related issues Aug 30, 2024
Your Patient Has Been Dealt a Hand With Four ACEs. What Now? In cancer survivorship, we must address patients' psychological wellness Aug 30, 2024
Benefits of Neoadjuvant Immunotherapy in Breast Cancer Extend Beyond TNBC Meta-analysis shows ICIs also improved pCR rates in HR-positive/HER2-negative disease Aug 29, 2024
Congresswomen Press FDA on Delayed Proposal to Ban Hair-Straightening Chemicals Agency has delayed the target date twice Aug 29, 2024
Lung Function Stable in Sickle Cell Patients After Non-Myeloablative Transplant Results from some pulmonary function tests even showed improvement 3 years post-transplant Aug 28, 2024
Is Exercise an Effective Treatment for Prostate Cancer? A deep dive with Rob Newton, a pioneer in the field of exercise oncology Aug 28, 2024
Lasting Reductions in CRC Incidence, Death With Single Sigmoidoscopy But editorialists call USPSTF-recommended screening option "outdated" Aug 27, 2024
